Search Login Register
capecitabine
(Xeloda)
Summary
Description:
a fluorouracil prodrug; Xeloda is tradename
Also Known As:
Xeloda; N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Networked: 2883
relevant articles (554 outcomes,
1268 trials/studies)
for this Drug
Key Diseases for which capecitabine is
Relevant
-
Breast Neoplasms (Breast Cancer)
:
175 outcomes 352 studies in 787 results
-
Colorectal Neoplasms (Colorectal Cancer)
:
145 outcomes 255 studies in 589 results
-
Neoplasms (Cancer)
:
71 outcomes 213 studies in 688 results
-
Stomach Neoplasms (Stomach Cancer)
:
52 outcomes 116 studies in 226 results
-
Rectal Neoplasms (Rectal Cancer)
:
33 outcomes 115 studies in 233 results
Show All >>
Drugs Related to capecitabine
-
oxaliplatin (Eloxatin)
-
Fluorouracil (Carac)
-
irinotecan (Camptosar)
-
docetaxel (Taxotere)
-
Cisplatin (Platino)
-
bevacizumab
-
Leucovorin (Folinic Acid)
-
capecitabine (Xeloda)
-
XELOX
-
gemcitabine
Show All >>
Therapies Related to capecitabine
-
Drug Therapy (Chemotherapy)
-
Radiotherapy
-
Combination Drug Therapy (Combination Chemotherapy)
-
Heterologous Transplantation (Xenotransplantation)
-
Adjuvant Chemotherapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.